Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Leap Therapeutics is a biopharmaceutical company that focuses on acquiring and developing antibody therapies for cancer treatment. Company is focused on developing targeted and immuno-oncology therapeutics. Goldman Sachs has rated Leap Therapeutics Inc. (DTIL) as a Strong Buy with a Buy rating. The consensus consensus is $1.55. The price target is $0.55, according to analysts.
Open: 1.36 Close: 1.41 Change: 0.05
Read more →Open: 2.21 Close: 2.23 Change: 0.02
Read more →